OCRIPLASMIN HAS PROTEOLYTIC ACTIVITY AGAINST PROTEIN COMPONENTS OF THE VITREOUS BODY AND THE VITREORETINAL INTERFACE (VRI) (E.G. LAMININ, FIBRONECTIN AND COLLAGEN), THEREBY DISSOLVING THE PROTEIN MATRIX RESPONSIBLE FOR THE VITREOMACULAR ADHESION (VMA).